Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immune globulin - Shanxi Kangbao Biological Product

Next Previous
Drug Profile

Immune globulin - Shanxi Kangbao Biological Product

Latest Information Update: 29 Aug 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shanxi Kangbao Biological Product
  • Class Anti-infectives; Anti-inflammatories; Antibacterials; Antidementias; Antifibrotics; Antivirals; Eye disorder therapies; Immunoglobulins; Immunoproteins; Polyethylene glycols; Serum globulins; Skin disorder therapies; Vascular disorder therapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Varicella zoster virus infections

Most Recent Events

  • 29 Aug 2023 Discontinued - Preclinical for Varicella zoster virus infections in China (unspecified route), prior to August 2023 (Shanxi Kangbao Biological Product pipeline, August 2023)
  • 28 Feb 2020 No recent reports of development identified for preclinical development in Varicella-zoster-virus-infections in China
  • 14 Jan 2016 Preclinical trials in Varicella zoster virus infections in China (unspecified route) prior to January 2016 (Shanxi Kangbao Biological Product pipeline, January 2016)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top